Accugenomics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Accugenomics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10448
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test and lung cancer diagnostic test. Accugenomics’ product candidates comprise LCDT-AGx-3 Gene lung cancer diagnostic tests that help improve diagnostic precision as an adjunct to morphological criteria and LCCT-AGx-4 Gene lung cancer chemoresistance test to estimate the response of different lung cancers to cisplatin or irinotecan related treatments. The company operates through its development laboratory in Wilmington. Accugenomics is headquartered in Wilmington, North Carolina, the US.

Accugenomics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Accugenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accugenomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Accugenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accugenomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Accugenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Accugenomics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Accugenomics to Raise Funds in Series A Financing Round 10
Partnerships 11
Accugenomics Enters into Licensing Agreement with University of Toledo 11
Nuclea Biotech Enters Into Co-Development Agreement With AccuGenomics 12
Accugenomics Inc – Key Competitors 13
Accugenomics Inc – Key Employees 14
Accugenomics Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Accugenomics Inc, Medical Equipment, Key Facts 2
Accugenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Accugenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accugenomics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Accugenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accugenomics Inc, Deals By Market, 2012 to YTD 2018 8
Accugenomics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Accugenomics to Raise Funds in Series A Financing Round 10
Accugenomics Enters into Licensing Agreement with University of Toledo 11
Nuclea Biotech Enters Into Co-Development Agreement With AccuGenomics 12
Accugenomics Inc, Key Competitors 13
Accugenomics Inc, Key Employees 14

List of Figures
Accugenomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Accugenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Accugenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Accugenomics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Accugenomics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Accugenomics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Accugenomics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Accugenomics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Accugenomics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Arab National Bank:企業の戦略・SWOT・財務分析
    Arab National Bank - Strategy, SWOT and Corporate Finance Report Summary Arab National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Novavax, Inc.:企業のM&A・事業提携・投資動向
    Novavax, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novavax, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Centrais Eletricas Brasileiras S.A. (ELET6):電力:M&Aディール及び事業提携情報
    Summary Centrais Eletricas Brasileiras S.A. (Eletrobras) is an electric utility. It generates, transmits, and distributes energy. The company produces electricity from hydro, nuclear, wind, natural gas, oil, coal, solar, and biomass sources. Eletrobras promotes the Latin American electric integratio …
  • Mologen AG (MGN):企業の財務・戦略的SWOT分析
    Summary Mologen AG (Mologen) is a biotechnology company that offers research and clinical development of novel drugs, immunotherapies and active ingredients. The company develops various pipeline products such as MGN1703, MGN1601, MGN1404, MGN1331 and MGN1333. It uses proprietary platform technologi …
  • Old Dominion Electric Cooperative:企業の戦略的SWOT分析
    Old Dominion Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • BioStar Pharmaceuticals Inc (BSPM):企業の財務・戦略的SWOT分析
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Bailian Group Co Ltd:企業の戦略的SWOT分析
    Bailian Group Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Continental AG:企業のM&A・事業提携・投資動向
    Continental AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Continental AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • TrueBlue Inc (TBI):企業の財務・戦略的SWOT分析
    Summary TrueBlue Inc (TrueBlue) is a talent solution company that provides filling individual positions on demand, staffing entire facilities and managing outsourced recruiting processes and staffing vendor programs. The company business division includes People Ready, Workforce Management and Peopl …
  • Toshiba America Medical Systems Inc:製品パイプライン分析
    Summary Toshiba America Medical Systems Inc (TAMS), a subsidiary of Toshiba Medical Systems Corp, is a medical device company which markets and distributes the diagnostic imaging systems. The company offers cardiovascular X-ray, computed tomography, angiography, magnetic resonance, ultrasound and x- …
  • Delta NV-エネルギー分野:企業M&A・提携分析
    Summary Delta N.V. (Delta) is an independent multi-utility company. It provides energy, network and infrastructure services, and digital services. The company generates electricity, transmits and trades in energy, and supplies gas and power. Delta provides cable services for both analogue and digita …
  • Eli Lilly and Co (LLY):企業の財務・戦略的SWOT分析
    Eli Lilly and Co (LLY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • JSS Medical Research Inc-製薬・医療分野:企業M&A・提携分析
    Summary JSS Medical Research Inc (JSS) is a contract research organization which offers clinical research services. It provides clinical trial services in various therapeutic areas that include cardiovascular disorders, oncology, infectious disease, neurology and psychiatry, autoimmune disorders, re …
  • Mannai Corporation QSC:企業のM&A・事業提携・投資動向
    Mannai Corporation QSC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mannai Corporation QSC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Britannia Industries Ltd (BRITANNIA):企業の財務・戦略的SWOT分析
    Britannia Industries Ltd (BRITANNIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Poudre Valley Rural Electric Association, Inc.:企業の戦略的SWOT分析
    Poudre Valley Rural Electric Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitor …
  • Henry Schein Inc (HSIC):企業の財務・戦略的SWOT分析
    Henry Schein Inc (HSIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Kratos Defense & Security Solutions, Inc.:企業の戦略・SWOT・財務情報
    Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Hindustan Organic Chemicals Limited (HOCL):企業の財務・戦略的SWOT分析
    Hindustan Organic Chemicals Limited (HOCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Collegium Pharmaceutical Inc (COLL)-医療機器分野:企業M&A・提携分析
    Summary Collegium Pharmaceutical Inc (Collegium) is a healthcare products provider that develops chronic pain and oral drug delivery solutions. The company's lead candidate, Xtampza ER, is an abuse-deterrent, extended-release, oral formulation of oxycodone that uses DETERx technology for the long-te …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆